Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The fibrosis of liver is a complication of chronic hepatitis C. There is actually no
established treatment for fibrosis of the liver. Pentoxyphilline and tocopherol may have an
activity on fibrosis. The aim of the study is to analyse the efficacy and the safety of the
combination with pentoxyphilline and tocopherol (12 months) on liver fibrosis, in patients
with chronic hepatitis C, who are non-long-term responders, or with intolerance or
contra-indication to interferon-alfa and ribavirin.
Phase:
Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E